InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Interest Income - Deposits (2017 - 2026)

InflaRx's (IFRX) quarterly Interest Income - Deposits came in at $803475.7 in Q2 2026, up 212.18% year-over-year from $257373.7 in Q2 2025, and up 115.73% quarter-over-quarter from $372449.3 in Q1 2026.

Analysis

InflaRx (IFRX) Interest Income - Deposits (2017 - 2026) Analysis & Trends

InflaRx has disclosed Interest Income - Deposits across 10 years of filings, most recently posting $803475.7 for Q2 2026.

  • In Q2 2026, Interest Income - Deposits rose 212.18% year-over-year to $803475.7; the TTM figure through Jun 2026 stood at $2.1 million (up 11.65% YoY), while the FY2025 annual figure was $2.0 million, down 18.07% from the prior year.
  • Interest Income - Deposits came in at $803475.7 for Q2 2026 at InflaRx, up from $372449.3 in the prior quarter.
  • In the past five years, Interest Income - Deposits ranged from a high of $951642.0 in Q1 2024 to a low of $224709.3 in Q2 2022.
  • Average Interest Income - Deposits over 5 years is $488505.6, with a median of $426929.0 recorded in 2023.
  • Year-over-year, Interest Income - Deposits jumped 1080.03% in 2022 and sank 51.59% in 2025.
  • Over 5 years, Interest Income - Deposits stood at $391318.9 in 2022, then climbed by 18.2% to $462539.0 in 2023, then slumped by 41.52% to $270507.4 in 2024, then increased by 29.8% to $351125.6 in 2025, then jumped by 128.83% to $803475.7 in 2026.
  • Per Business Quant data, the three most recent Interest Income - Deposits figures were $803475.7 in Q2 2026, $372449.3 in Q1 2026, and $351125.6 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Deposits (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 803,475.66
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 803,475.66
Mar 31, 2026 372,449.31
Dec 31, 2025 351,125.58
Sep 30, 2025 620,145.15
Jun 30, 2025 257,373.67
Mar 31, 2025 713,931.85
Dec 31, 2024 270,507.45
Sep 30, 2024 681,317.81
Jun 30, 2024 531,637.86
Mar 31, 2024 951,642.04
Dec 31, 2023 462,539.04
Sep 30, 2023 812,440.11
Jun 30, 2023 337,672.19
Mar 31, 2023 264,010.96
Dec 31, 2022 391,318.94
Sep 30, 2022 274,394.80
Jun 30, 2022 224,709.33
Mar 31, 2022 472,409.90
Dec 31, 2021 716,931.17
Sep 30, 2021 84,750.66